Published 11/05/2009 by Drug Discovery News
BrainStorm to complete experiments for Harlan Biotech
NEW YORK-, a developer of adult stem cell technologies and therapeutics, announced in October that it has entered into a strategic agreement with , a Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's...
Share this
There are no more reports on this story yet.